Cue Biopharma (CUE) Cash from Investing Activities (QoQ) (2017 - 2025)
Cue Biopharma (CUE) Cash from Investing Activities (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cue Biopharma |
581.16 Mn |
553.47 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
203.72% |
| Sep 30, 2025 |
-24,966.67% |
| Jun 30, 2025 |
82.00% |
| Mar 31, 2025 |
-14,900.00% |
| Dec 31, 2024 |
-101.02% |
| Sep 30, 2024 |
1,080.00% |
| Jun 30, 2024 |
81.82% |
| Sep 30, 2023 |
0.00% |
| Jun 30, 2023 |
-66.67% |
| Mar 31, 2023 |
200.10% |
| Dec 31, 2022 |
116.93% |
| Sep 30, 2022 |
-47,512.90% |
| Jun 30, 2022 |
-129.63% |
| Mar 31, 2022 |
-5,383.76% |
| Dec 31, 2021 |
104.65% |
| Sep 30, 2021 |
95.28% |
| Jun 30, 2021 |
-102.49% |
| Mar 31, 2021 |
-5.46% |
| Dec 31, 2020 |
112.55% |
| Sep 30, 2020 |
3,424.29% |
